Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 4/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.55 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.55 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.46 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.46 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.46 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.44 |
| ▸ | PPARG | P37231 | 5/20 | 0.44 |
| ▸ | PPARD | Q03181 | 5/20 | 0.44 |
| ▸ | PPARA | Q07869 | 5/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | TLR2 | O60603 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3504717 | 0.83 | EGLN1 (0.53) | LMNATSHRNFKB1PMP22SLC22A6 | |
| SCHEMBL3505562 | 0.83 | AKR1B1 (0.58) | TSHRSLC22A6GPR84FFAR1FFAR4 | |
| SCHEMBL13644170 | 0.81 | GPR84 (0.60) | LMNATSHRSLC22A6GPR84FFAR1 | |
| SCHEMBL3504001 | 0.81 | GPR84 (0.60) | LMNATSHRSLC22A6GPR84FFAR1 | |
| SCHEMBL11331526 | 0.81 | TSHR (0.52) | LMNATSHRNFKB1PMP22SLC22A6 | |
| SCHEMBL11340981 | 0.81 | TSHR (0.52) | LMNATSHRNFKB1PMP22SLC22A6 | |
| SCHEMBL11387826 | 0.81 | TSHR (0.52) | LMNATSHRNFKB1PMP22SLC22A6 | |
| SCHEMBL17706766 | 0.81 | LMNA (0.61) | LMNATSHRNFKB1PMP22SLC22A6 | |
| SCHEMBL3504184 | 0.80 | SLC22A6 (0.69) | LMNATSHRNFKB1PMP22SLC22A6 | |
| SCHEMBL3504677 | 0.80 | AKR1B1 (0.48) | TSHRSLC22A6GPR84FFAR1FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220339259-A1 | ORALLY DELIVERED THERAPEUTICAL COMPOSITION AND USE THEREOF | SHEN HAIFA (US) | 2022-10-27 | — | — | US | disclosed |
| CN-114466658-A | Orally delivered therapeutic compositions and uses thereof | 沈海发 | 2022-05-10 | — | — | CN | disclosed |
| WO-2021046497-A2 | ORALLY DELIVERED THERAPEUTICAL COMPOSITION AND USE THEREOF | SHEN HAIFA (US) | 2021-03-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220339259-A1 | ORALLY DELIVERED THERAPEUTICAL COMPOSITION AND USE THEREOF | FABP2, SLC27A1, SLC27A2 | LMNA 2441/4885TSHR 4550/4885NFKB1 2951/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.